Universität zu Köln

Schildgen, Verena, Luesebrink, Jessica, Schildgen, Oliver ORCID: 0000-0003-4297-9627, Stoelben, Erich and Brockmann, Michael (2016). Epidemiology of driver mutations in lung cancer in a German tertiary hospital in patients with testing indication. Pers. Med., 13 (4). S. 315 - 324. LONDON: FUTURE MEDICINE LTD. ISSN 1744-828X

Full text not available from this repository.

Abstract

Background: KRAS, BRAF, EGFR and ALK-mutation testing is a prerequisite for non-small-cell lung cancer treatments, but there remains limited epidemiological information about such mutations in German cohorts. Materials & methods: Between February 2010 and June 2015, a total of 1080 tumor samples from 1019 non-small-cell lung cancer patients were analyzed for KRAS, BRAF, EGFR and ALK-mutations by Therascreen-pyrosequencing and FISH. Results: Mutation patterns differed dependent on the histological subtype and sex. Mainly, adenocarcinomas were mutated and formed the major histological group. Double mutations were observed also not explicitly screened for. In our German cohort, female adenocarcinoma patients had statistically significantly higher rates EGFR mutations than male patients. Discussion: The different mutation patterns dependent on histological phenotypes warrant further epidemiological studies while suggesting different mechanisms of cancerogenesis.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Schildgen, Verena UNSPECIFIED UNSPECIFIED UNSPECIFIED Luesebrink, Jessica UNSPECIFIED UNSPECIFIED UNSPECIFIED Schildgen, Oliver UNSPECIFIED orcid.org/0000-0003-4297-9627 UNSPECIFIED Stoelben, Erich UNSPECIFIED UNSPECIFIED UNSPECIFIED Brockmann, Michael UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-270876
DOI:	10.2217/pme.16.2
Journal or Publication Title:	Pers. Med.
Volume:	13
Number:	4
Page Range:	S. 315 - 324
Date:	2016
Publisher:	FUTURE MEDICINE LTD
Place of Publication:	LONDON
ISSN:	1744-828X
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language GROWTH-FACTOR RECEPTOR; POSITIVE PATIENTS; EGFR MUTATIONS; NSCLC; THERAPY; KRAS; GEFITINIB; ERLOTINIB; CHEMOTHERAPY; INHIBITORS Multiple languages Pharmacology & Pharmacy Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/27087